Introduction
Assay
|
Sample type
|
Adhesion
|
Aggregation
|
Coagulation
|
Endothelium
|
Shear
|
No. of citations
| |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasma | PRP | WB | Init. | Prop. | Elast. | Lysis | ||||||
Multiplate |
-
|
+
|
+
|
-
|
+
|
-
|
-
|
-
|
-
|
-
|
-
| 250 |
VerifyNow |
-
|
-
|
+
|
-
|
+
|
-
|
-
|
-
|
-
|
-
|
-
| 476 |
Plateletworks |
-
|
-
|
+
|
-
|
+
|
-
|
-
|
-
|
-
| - |
-
| 26 |
Impact-R |
-
|
-
|
+
|
+
|
+
|
-
|
-
|
-
|
-
|
-
|
+
| 121 |
PFA-100 |
-
|
-
|
+
|
+
|
+
|
-
|
-
|
-
|
-
|
-
|
+
| 745 |
Perfusion chambers |
-
|
-
|
+
|
+
|
+
| (+) | (+) |
-
|
-
| (+) |
+
| 630 |
TEG | (+) |
+
|
+
|
-
|
-
|
-
|
+
|
+
|
+
|
-
|
-
| 4016 |
ROTEM | (+) |
+
|
+
|
-
|
-
|
-
|
+
|
+
|
+
|
-
|
-
| 3932 |
ReoRox | (+) |
+
|
+
|
-
|
-
|
+
|
+
|
+
|
+
|
-
|
-
| 28 |
Sonoclot | (+) |
+
|
+
|
-
|
-
|
+
|
+
|
+
|
+
|
-
|
-
| 113 |
Thrombin generation |
+
|
+
|
−
|
-
|
-
|
+
|
+
|
−
|
−
|
-
|
-
| 118 |
OHP |
+
|
−
|
−
|
-
|
-
| + | (+) |
-
|
+
|
-
|
-
| 23 |
Thrombodynamics |
+
|
+
|
+
|
-
|
-
|
+
|
+
|
−
|
−
|
-
|
-
| 11 |
Tests of primary haemostasis
Aggregometry
Adhesion assays
Tests of secondary/global haemostasis
Viscoelastic haemostatic assays (VHA)
TEG
|
ROTEM
|
ReoRox
|
---|---|---|
KaolinTEG
|
InTEM
|
HepScreen1
|
Kaolin (intrinsic pathway activation) | Intrinsic pathway activation, sensitive to heparin | TP (extrinsic pathway, sensitive to heparin) |
HepTEG
|
HepTEM
|
HepScreen2
|
Heparin neutralising cup | Intrinsic pathway activation + heparin neutralisation | TP (extrinsic pathway + heparin neutralization) |
RapidTEG
|
ExTEM
|
FibScreen1
|
Kaolin + TF activation | TF activation (extrinsic pathway) | TP (extrinsic pathway) |
Functional fibrinogen TEG (FFTEG)
|
FibTEM
|
FibScreen2
|
TF activation + platelet inhibition with abciximab | TF activation + platelet inhibition with cytochalasin | TP activation + platelet inhibition with abciximab) |
FibTEM+
| ||
TF activation + platelet inhibition with cytochalasin and tirofiban (under development) | ||
Platelet Mapping Kit
|
ApTEM
|
ReoTrap
|
(ADP, AA) | (TF activation + aprotinin, verification of fibrinolysis) | PAR-1 activation |